ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646381 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646381; 2) Community: the network communities that were significantly associated with the response to NSC 646381; 3) Molecule: the relationships between components within communities and NSC 646381; 4) MDR: the compounds that were significantly associated with the NSC 646381.

NSC Compound Enrichment Correlation
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.017498903403062 0.37209145
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.017498903403062 0.20755601
NSC 740 Methotrexate 0.017498903403062 0.44522853
NSC 748715 Null 0.017498903403062 0.45512207
NSC 754245 5-(2-(dimethylamino)ethyl)-2,8-dimethoxy-5H-indeno[1,2-c]quinoline-6,11-dione 0.017498903403062 0.43118918
NSC 756404 GW843682X 0.017498903403062 0.28996324
NSC 139105 Soluble Baker's Antifol 0.0174989034030623 0.30000029
NSC 176507 Fastigilin C 0.0174989034030623 0.36416256
NSC 382034 2,4-Pyrimidinediamine, 6-ethyl-5-[4-(methylamino)- 3-nitrophenyl]- 0.0174989034030623 0.4629834
NSC 627618 Null 0.0174989034030623 0.39745945
Total:90  Current:36    [First] [Prev] [Next] [Last]